ArticleNorthern clinics of Istanbul2026
Thoracic ultrasonography-guided biopsy: Radiological and radiometabolic factors affecting diagnostic success.
Article in Northern clinics of Istanbul, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveInvestigate radiologic and radiometabolic features affecting the diagnostic success of transthoracic biopsy (TTB) procedures guided by Thoracic Ultrasonography (TUS).
methodsThe electronic medical records of all patients who underwent TUS-guided TTB procedures (TUS-TBB) were retrospectively reviewed. Patients with a final diagnosis of primary lung cancer (LC), established via TUS-TBB or other diagnostic modalities, were included in the study. The cohort was stratified into two groups: those in whom the TUS-TBB procedure was diagnostic and those in whom it was non-diagnostic. Clinical, demographic, radiological [Chest Computed Tomography (CT)], and radiometabolic (PET-CT) characteristics were compared between the two groups.
resultsA total of 107 patients with a final diagnosis of lung cancer were included in the study. Of these, 91 (85%) were male, with a mean age of 67.8±11.4 years. The mean maximum diameter of the mass lesion on chest CT was 68.2±31 millimeters (mm), and the mean maximum standardized uptake value (SUV
conclusionTUS-TBB procedures demonstrate high diagnostic success. In carefully selected patients, pre-procedural evaluation of lesion metabolic activity using PET-CT may enhance the diagnostic success of the biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.